Investigation of malaria susceptibility determinants in the IFNG/IL26/IL22 genomic region

Genes and Immunity

Volumn 6, Issue 4, 2005, Pages 312-318

  Kock, O ^a,b   Rockett, Kirk ^a   Jallow, M ^c   Pinder, M ^c   Sisay Joof, F ^c   Kwiatkowski, D ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Anaemia; Cerebral malaria; IFNG; IL22; IL26; Interferon ; Malaria; Microsatellite

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 22; INTERLEUKIN 26;

AFRICA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOME; HAPLOTYPE; HUMAN; INFECTION; INFLAMMATORY DISEASE; MALARIA; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LINKAGE DISEQUILIBRIUM; MALARIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 21344433481     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364214     Document Type: Article

References (30)

1. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827-845.
2. Chehimi J, Trinchieri G. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 1994; 14: 149-161.
3. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
4. Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M et al. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000; 356: 820-825.
5. Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, Sinnott PJ et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 1999; 60: 343-346.
6. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594-1600.
7. Nagarkatti R, Rao CB, Rishi JP, Chetiwal R, Shandilya V, Vijayan V et al. Association of IFNG gene polymorphism with asthma in the Indian population. J Allergy Clin Immunol 2002; 110: 410-412.
8. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863-866.
9. Lio D, Marino V, Serauto A, Gioia V, Scola L, Crivello A et al. Genotype frequencies of the +874T→a single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 2002; 29: 371-374.
10. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R, Madero R et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 167: 970-975.
11. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004; 4: 169-180.
12. Schofield L, Ferreira A, Altszuler R, Nussenzweig V, Nussenzweig RS. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol 1987; 139: 2020-2025.
13. Sedegah M, Finkelman F, Hoffman SL. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci USA 1994; 91: 10700-10702.
14. Hoffman SL, Crutcher JM, Puri SK, Ansari AA, Villinger F, Franke ED et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med 1997; 3: 80-83.
15. Grau GE, Heremans H, Piguet PF, Pointaire P, Lambert PH, Billiau A et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 1989; 86: 5572-5574.
16. Grau GE, Piguet PF, Vassalli P, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev 1989; 112: 49-70.
17. Johnson JK, Swerlick RA, Grady KK, Millet P, Wick TM. Cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelium is regulatable by cytokines and phorbol ester. J Infect Dis 1993; 167: 698-703.
18. Vannucchi AM, Grossi A, Rafanelli D, Statello M, Cinotti S, Rossi-Ferrini P. Inhibition of erythropoietin production in vitro by human interferon gamma. Br J Haematol 1994; 87: 18-23.
19. Riley EM, Jakobsen PH, Allen SJ, Wheeler JG, Bennett S, Jepsen S et al. Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children. Eur J Immunol 1991; 21: 1019-1025.
20. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929-979.
21. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241-254.
22. Chevillard C, Henri S, Stefani F, Parzy D, Dessein A. Two new polymorphisms in the human interferon gamma (IFN-gamma) promoter. Eur J Immunogenet 2002; 29: 53-56.
23. Bream JH, Carrington M, O'Toole S, Dean M, Gerrard B, Shin HD et al. Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 2000; 51: 50-58.
24. Ross P, Hall L, Smirnov I, Haff L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998; 16: 1347-1351.
25. Ackerman H, Usen S, Mott R, Richardson A, Sisay-Joof F, Katundu P et al. Haplotypic analysis of the TNF locus by association efficiency and entropy. Genome Biol 2003; 4: R24.
26. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
27. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001; 294: 1719-1723.
28. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71: 441-459.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
30. Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature 1982; 298: 859-863.